MEDIA, Pa., March 8 /PRNewswire-FirstCall/ -- Synova Healthcare Group, Inc. , developers and distributors of rapid over-the-counter and point-of-care diagnostic tests, announced today that its shares have also been listed on the Frankfurt Stock Exchange under the symbol "S7H," and the security number US87163H1023.
"European investors have recently shown strong interest in our corporate mission, our product portfolio and our management team at Synova Healthcare," stated Stephen King, Chief Executive Officer. "The Frankfurt exchange listing will provide both institutional and retail investors in Europe with a direct ability to trade our company's shares, further enhancing our liquidity and visibility."
About the Frankfurt Stock Exchange:
------------------------
The Frankfurt Stock Exchange (FWB) is one of the world's largest securities trading centers and it is the largest of the eight German stock exchanges. Operated by Deutsche Borse AG, the FWB facilitates advanced electronic trading, settlement and information systems. In addition to traditional floor trading, the exchange offers leading electronic trading platform capability through Xetra(R). For more information please visit the Frankfurt Stock Exchange's website at http://deutsche-boerse.com.
About Synova Healthcare Group, Inc.:
------------------------
Synova Healthcare Group, Inc., (SNVH), presently operates two wholly owned subsidiaries: Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc. The company distributes rapid, non-invasive medical diagnostics to retail for over-the-counter (OTC) use, and directly to health care providers for point of care (POC) use in the clinical setting. The company's products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Such risk factors are discussed in the Company's Form SB-2 registration statement (File No. 333-123498), filed with the Securities and Exchange Commission on August 10, 2005, as well as in periodic reports filed with the Commission. There can be no assurance that such factors will not affect the accuracy of such forward-looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Corporate Contact Information: Synova Healthcare Group, Inc Attn: Mr. Robert Edwards, CFO 1400 N. Providence Road, Ste. 6010 Media, PA 19063 Tel: 610-565-7080 Fax: 610-565-7081 http://www.synovahealthcare.com Inquiries may also be directed to: info@synovahealthcare.com
Synova Healthcare Group, Inc.CONTACT: Robert Edwards, CFO, Synova Healthcare Group, +1-610-565-7080 orFax: +1-610-565-7081
Web site: http://www.synovahealthcare.com//
